Payers worldwide are struggling with a new generation of precision medicines that come with a hefty price tag. Ben Hargreaves finds that the UK’s NICE is once again caught between ensuring ...
This Genome Watch discusses the great biosynthetic capacity that has been identified in marine environmental and host-associated microbiomes, along with approaches to facilitate research into these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback